Jonas Hahn

Jonas Hahn

Auto-generated profile, based on publicly available information

Jonas Hahn

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen 1 , Erlangen

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2017 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
ACAndrea Cossarizza
Andrea Cossarizza
HCHyun-Dong Chang
Hyun-Dong Chang
ARAndreas Radbruch
Andreas Radbruch
MAMübeccel Akdis
Mübeccel Akdis
IAImmanuel Andrä
Immanuel Andrä
JZJakob Zimmermann
Jakob Zimmermann
International audienceThe classical model of hematopoiesis established in the mouse postulates that lymphoid cells originate from a founder population of common lymphoid progenitors. Here, using a modeling approach in humanized mice, we showed that human lymphoid development stemmed from distinct populations of CD127(-) and CD127(+) early lymphoid progenitors (ELPs). Combining molecular analyses with in vitro and in vivo functional assays, we demonstrated that CD127(-) and CD127(+) ELPs emerged independently from lympho-mono-dendritic progenitors, responded differently to Notch1 signals, underwent divergent modes of lineage restriction, and displayed both common and specific differentiation potentials. Whereas CD127(-) ELPs comprised precursors of T cells, marginal zone B cells, and natural killer (NK) and innate lymphoid cells (ILCs), CD127(+) ELPs supported production of all NK cell, ILC, and B cell populations but lacked T potential. On the basis of these results, we propose a "two-family" model of human lymphoid development that differs from the prevailing model of hematopoiesis

8 January 2019 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
SBSebastian Boeltz
Sebastian Boeltz
PAPoorya Amini
Poorya Amini
HAHans-Joachim Anders
Hans-Joachim Anders
FAFelipe Andrade
Felipe Andrade
Rostyslav BilyyRostyslav Bilyy
Rostyslav Bilyy
MHMartin Herrmann
Martin Herrmann
Since the discovery and definition of neutrophil extracellular traps (NETs) 14 years ago, numerous characteristics and physiological functions of NETs have been uncovered. Nowadays, the field continues to expand and novel mechanisms that orchestrate formation of NETs, their previously unknown properties, and novel implications in disease continue to emerge. The abundance of available data has also led to some confusion in the NET research community due to contradictory results and divergent scientific concepts, such as pro- and anti-inflammatory roles in pathologic conditions, demarcation from other forms of cell death, or the origin of the DNA that forms the NET scaffold. Here, we present prevailing concepts and state of the science in NET-related research and elaborate on open questions and areas of dispute.

1 September 2019 in Immunity
Verified
Journal Article
Closed access
LMLuis E. Muñoz
Luis E. Muñoz
SBSebastian Boeltz
Sebastian Boeltz
Rostyslav BilyyRostyslav Bilyy
Rostyslav Bilyy
CSChristine Schauer
Christine Schauer
AMAparna Mahajan
Aparna Mahajan
Martin HerrmannMartin Herrmann
Martin Herrmann

19 September 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Luis MunozLuis Munoz
Luis Munoz
Rostyslav BilyyRostyslav Bilyy
Rostyslav Bilyy
MBMona H. C. Biermann
Mona H. C. Biermann
DKDeborah Kienhöfer
Deborah Kienhöfer
CMChristian Maueröder
Christian Maueröder
Martin HerrmannMartin Herrmann
Martin Herrmann
Significance: The current widespread exposure of humans to natural as well as man-made nanomaterials due to the deployment of nanoparticles (NPs) as food additives, as vaccine- or drug-delivery vehicles, and in diagnostic procedures encourages the evaluation of their interaction with the innate immune system. Understanding how organisms cope with hydrophobic and chemically inert particulate matter, which is excluded from metabolic processing, is of major importance for interpreting the responses associated with the use of NPs in the biosphere. The containment of NPs within neutrophil-derived aggregates locally orchestrates the resolution of inflammation. Overriding this mechanism bears the risk of inducing chronic inflammation and causing tissue damage.

21 August 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
JHJonas Hahn
Jonas Hahn
CSChristine Schauer
Christine Schauer
CCChristine Czegley
Christine Czegley
LKLasse Kling
Lasse Kling
LPLenka Petru
Lenka Petru
MHMarkus H Hoffmann
Markus H Hoffmann
Papillon‐Lefèvre syndrome (PLS) is characterized by nonfunctional neutrophil serine proteases (NSPs) and fulminant periodontal inflammation of unknown cause. Here we investigated neutrophil extracellular trap (NET)‐associated aggregation and cytokine/chemokine‐release/degradation by normal and NSP‐deficient human and mouse granulocytes. Stimulated with solid or soluble NET inducers, normal neutrophils formed aggregates and both released and degraded cytokines/chemokines. With increasing cell density, proteolytic degradation outweighed release. Maximum output of cytokines/chemokines occurred mostly at densities between 2 × 10 7 and 4 × 10 7 neutrophils/cm 3 . Assessment of neutrophil density in vivo showed that these concentrations are surpassed during inflammation. Association with aggregated NETs conferred protection of neutrophil elastase against αl‐antitrypsin. In contrast, eosinophils did not influence cytokine/chemokine concentrations. The proteolytic degradation of inflammatory mediators seen in NETs was abrogated in Papillon–Lèfevre syndrome (PLS) neutrophils. In summary, neutrophil‐driven proteolysis of inflammatory mediators works as a built‐in safeguard for inflammation. The absence of this negative feedback mechanism might be responsible for the nonresolving periodontitis seen in PLS.—Hahn, J., Schauer, C., Czegley, C., Kling, L., Petru, L., Schmid, B., Weidner, D., Reinwald, C., Biermann, M. H. C., Blunder, S., Ernst, J., Lesner, A., Bäuerle, T., Palmisano, R., Christiansen, S., Herrmann, M., Bozec, A., Gruber, R., Schett, G., Hoffmann, M. H. Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases. FASEB J. 33, 1401–1414 (2019). www.fasebj.org

18 May 2017 in JCI Insight
Verified
Journal Article
Closed access
PDF file
DKDeborah Kienhöfer
Deborah Kienhöfer
JHJonas Hahn
Jonas Hahn
JSJulia Stoof
Julia Stoof
JCJanka Zsófia Csepregi
Janka Zsófia Csepregi
CRChristiane Reinwald
Christiane Reinwald
MHMarkus H Hoffmann
Markus H Hoffmann
Many effector mechanisms of neutrophils have been implicated in the pathogenesis of systemic lupus erythematosus (SLE). Neutrophil extracellular traps (NETs) have been assigned a particularly detrimental role. Here we investigated the functional impact of neutrophils and NETs on a mouse model of lupus triggered by intraperitoneal injection of the cell death–inducing alkane pristane. Pristane-induced lupus (PIL) was aggravated in 2 mouse strains with impaired induction of NET formation, i.e., NOX2-deficient ( Ncf1 -mutated) and peptidyl arginine deiminase 4–deficient (PAD4-deficient) mice, as seen from elevated levels of antinuclear autoantibodies (ANAs) and exacerbated glomerulonephritis. We observed a dramatically reduced ability to form pristane-induced NETs in vivo in both Ncf1 -mutated and PAD4-deficient mice, accompanied by higher levels of inflammatory mediators in the peritoneum. Similarly, neutropenic Mcl-1 ΔMyelo mice exhibited higher levels of ANAs, which indicates a regulatory function in lupus of NETs and neutrophils. Blood neutrophils from Ncf1 -mutated and human individuals with SLE exhibited exuberant spontaneous NET formation. Treatment with specific chemical NOX2 activators induced NET formation and ameliorated PIL. Our findings suggest that aberrant NET is one of the factors promoting experimental lupus-like autoimmunity by uncontrolled release of inflammatory mediators.